Cambridge Biotech Wants Workers To Understand Patients' Diet Experience

December 06, 2017 | Biotech companies developing drugs for rare diseases often invite patients to visit so workers can put a human face on illnesses that could be viewed as abstract scientific puzzles. Akcea Therapeutics is taking that idea further - it wants staffers to get a taste of life with a super-rare metabolic disorder. The Boston Globe